Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G2SI
|
|||
| Drug Name |
Pyrazolo-triazine derivative 1
|
|||
| Synonyms |
PMID26161698-Compound-13
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
LEAD DISCOVERY CENTER GMBH
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H28N6O
|
|||
| Canonical SMILES |
CC(C)C1=C2N=C(N=C(N2N=C1)NC(C)C3=CC=CC=C3)OC4CCCNC4
|
|||
| InChI |
1S/C21H28N6O/c1-14(2)18-13-23-27-19(18)25-21(28-17-10-7-11-22-12-17)26-20(27)24-15(3)16-8-5-4-6-9-16/h4-6,8-9,13-15,17,22H,7,10-12H2,1-3H3,(H,24,25,26)/t15-,17?/m0/s1
|
|||
| InChIKey |
GTZAVJAMAXSTOG-MYJWUSKBSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.